[HTML][HTML] Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over …
N Ning, X Liu, C Bao, S Chen, E Cui, J Zhang… - BMC infectious …, 2017 - Springer
Abstract Background Carbapenem-resistant Acinetobacter baumannii poses a significant
threat to hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
threat to hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
Molecular epidemiology of bla OXA-23-producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China
NZ Ning, X Liu, CM Bao, SM Chen… - BMC infectious …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Carbapenem-resistant Acinetobacter baumannii poses a significant threat to
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
Molecular epidemiology of blaOXA-23-producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China
N Ning, X Liu, C Bao, S Chen, E Cui, J Huang… - BMC Infectious …, 2017 - go.gale.com
Background Carbapenem-resistant Acinetobacter baumannii poses a significant threat to
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
[PDF][PDF] Molecular epidemiology of blaOXA-23-producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China
F Chen, T Li, F Qu, H Wang - 2017 - cyberleninka.org
Abstract Background: Carbapenem-resistant Acinetobacter baumannii poses a significant
threat to hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
threat to hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
Molecular epidemiology of bla OXA-23-producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China
N Ning, X Liu, B Chun-mei, C Su-ming… - BMC Infectious …, 2017 - search.proquest.com
Background Carbapenem-resistant Acinetobacter baumannii poses a significant threat to
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
[HTML][HTML] Molecular epidemiology of bla OXA-23-producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China
N Ning, X Liu, C Bao, S Chen… - BMC Infectious …, 2017 - bmcinfectdis.biomedcentral.com
Carbapenem-resistant Acinetobacter baumannii poses a significant threat to hospitalized
patients, as few therapeutic options remain. Thus, we investigated the molecular …
patients, as few therapeutic options remain. Thus, we investigated the molecular …
Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China.
NZ Ning, X Liu, CM Bao, SM Chen, EB Cui… - BMC Infectious …, 2017 - europepmc.org
Background Carbapenem-resistant Acinetobacter baumannii poses a significant threat to
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
[HTML][HTML] Molecular epidemiology of blaOXA-23-producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China
N Ning, X Liu, C Bao, S Chen, E Cui… - BMC Infectious …, 2017 - ncbi.nlm.nih.gov
Background Carbapenem-resistant Acinetobacter baumannii poses a significant threat to
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
Molecular epidemiology of blaOXA-23-producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China
N Ning, X Liu, C Bao, S Chen, E Cui, J Zhang… - BMC Infectious …, 2017 - infona.pl
Background Carbapenem-resistant Acinetobacter baumannii poses a significant threat to
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China.
NZ Ning, X Liu, CM Bao, SM Chen, EB Cui… - BMC Infectious …, 2017 - europepmc.org
Background Carbapenem-resistant Acinetobacter baumannii poses a significant threat to
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …
hospitalized patients, as few therapeutic options remain. Thus, we investigated the …